Director, Health Technology Assessment & Operations jobs in United States
info-icon
This job has closed.
company-logo

Cencora · 1 month ago

Director, Health Technology Assessment & Operations

Cencora is an innovative company dedicated to creating healthier futures. They are seeking a Director of Health Technology Assessment & Operations to provide strategic leadership in health technology assessment, manage client relationships, and oversee operational excellence across various projects.

Emergency MedicineEnterprise SoftwareHealth CareMedicalPharmaceutical

Responsibilities

Provide HTA (Health Technology Assessment) expertise and leadership to further develop our ongoing expertise in the area
Provide specific HTA strategic insights and leadership during client consultations, presentations, and project deliverables
Work collaboratively across multiple programs and divisions to identify, develop, and close new consulting opportunities
Oversee operational components such as monthly billable processes, client project plans, deliverables, and divisional project management ensuring operational excellence and high-quality outcomes
Serve as a primary point of contact for senior-level clients, building and maintaining strong relationships to support business growth and client satisfaction
Lead client portfolio management, ensuring client projects are executed on time and within budget
Collaborate on the New Business Development (NBD) strategy, including capability presentations, pursuing new business opportunities, and responding to client requests
Strategically contributes to market access strategies to address client needs and grow business opportunities
Manage and mentor direct reports, fostering a collaborative and high-performing team environment
Ensure project plans are met with clear timelines, deliverables, and guidance to ensure on-time and on-budget completion
Lead cross-functional teams to generate business success and support team objectives
Build and maintain professional networks to profile Innomar’s services, capabilities, and expertise in the healthcare industry
Enhance Innomar’s brand recognition through strategic client communication, relationship management, and industry engagement

Qualification

Health Technology AssessmentMarket AccessProject ManagementClient ManagementBilingualism (French/English)Leadership SkillsMicrosoft Office ProficiencyInterpersonal SkillsPresentation SkillsOrganizational Skills

Required

Bachelor's degree in life sciences, business administration, or healthcare policy; an MBA is an asset
A minimum of 8–10 years of proven strategic leadership experience and demonstrated success in Canadian Health Technology Assessment (HTA) and Market Access within the pharmaceutical and healthcare sectors
Demonstrated excellence in consulting operations, project management and client management
Proven leadership and project management skills, with the ability to manage multiple priorities and meet deadlines
Excellent interpersonal and leadership skills, with the ability to inspire and develop team members
Extensive knowledge of the Canadian HTA and Market Access processes and stakeholders for health technologies
Advanced presentation skills, with the ability to communicate complex concepts clearly and effectively
Excellent oral and written communication skills for engaging with both internal teams and external clients
Exceptional organizational skills and attention to detail
Proficiency in Microsoft Word, Excel, PowerPoint, and other Office programs
Ability to maintain confidentiality and exercise sound judgment when interacting with clients

Preferred

Bilingualism (French/English) is an asset

Benefits

Medical, dental, and vision care
Backup dependent care
Adoption assistance
Infertility coverage
Family building support
Behavioral health solutions
Paid parental leave
Paid caregiver leave
Training programs
Professional development resources
Opportunities to participate in mentorship programs
Employee resource groups
Volunteer activities

Company

Cencora is a global healthcare company that advances the development and delivery of pharmaceuticals and healthcare products.

Funding

Current Stage
Public Company
Total Funding
$4.83B
2024-12-02Post Ipo Debt· $1.8B
2024-02-05Post Ipo Debt· $500M
2022-11-07Post Ipo Secondary· $500M

Leadership Team

leader-logo
Robert Mauch
President and Chief Executive Officer
linkedin
leader-logo
Mike Baca
Senior Director, AI Platforms & Solutions
linkedin
Company data provided by crunchbase